The Long Window of Preclinical Alzheimer’s Disease: Opportunities for Intervention

Posted June 9, 2017

David Holtzman, M.D., joined us for a WebEx conference on Alzheimer’s and the work he is doing to help us better understand and treat the disease.

Share:

Rudy Tanzi, PH.D.: Neuroinflammation and Alzheimer’s Disease

Back to News and Events

Alzstream™ Webinar: Alzheimer’s and the Gut Microbiome

Related Content:

June 7 2022

The Story of Cure Alzheimer’s Fund

Perspectives on How Philanthropy and Venture Capital Must Partner to Translate Lab Discoveries Into Meaningful Benefits for Alzheimer’s Disease Patients

April 8 2022

New Drug for Alzheimer’s Disease – ADUHELM – Update

January 11 2022

2:19 pm

2nd Annual Robert Moir Memorial Lecture, Thursday, January 13th – 3:00PM EST

December 7 2021

Jerome L. Rappaport (August 17, 1927 – December 5, 2021)

December 7 2021

DECREASED EXPRESSION OF CCR7 MAY UNDERLIE AGING-RELATED COGNITIVE DECLINE